Intron A

Interferon Alfa-2B

8.0 High risk

Intron A & Product use in unapproved indication

18.9%

of users reported Product use in unapproved indication

53.8%

also reported Severe reaction

50.0%

are men

Most common medical consequences

Severe reaction
53.8%
Hospitalization
28.2%
Death
15.4%
Disability
2.6%

Have you experienced any negative side effects from this medication?

Intron A: general information

Most common side effects (30)

Most commonly affected ages

0 - 9 years
1.1%
10 - 19 years
<0.1%
20 - 29 years
1.4%
30 - 39 years
9.9%
40 - 49 years
19.7%
50 - 59 years
22.0%
60 - 69 years
29.2%
70 - 79 years
15.3%
80 - 89 years
1.5%
On this page
Intron A & Product use in unapproved indication
Intron A: general information